Clinical trial
REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)
NCT05632809
Study timeline
Study start (actual)2023-01-10Date precision: day
Registry last updated2026-07-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
NKTR-255DRUG
DurvalumabDRUG · verified · RxNorm: durvalumab
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
Nektar Therapeuticscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05632809 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.